B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

EBioMedicine

Topics

Biology

Bioinformatics

Medicine

Biochemistry

Cancer Oncology

Show all topics

DOI

10.1016/j.ebiom.2024.105459

License

CC-BY-NC-ND